Kymera Therapeutics, Inc. ($KYMR)
Filing Information
| Accession Number | 0001193125-26-217041 |
|---|---|
| Form Type | 4 |
| Filing Date | May 11, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
9,000
Total Value
$354,600.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | May 11, 2026 | Exercise/Conversion | 3,000 | $31.20 | $93,600.00 | 3,000 | Direct | โ | View Details | |
Director | Common Stock | โ | May 11, 2026 | Sale | 3,000 | $87.00 | $261,000.00 | 0 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | May 11, 2026 | Exercise/Conversion | 3,000 | $0.00 | $0.00 | 13,000 | Direct | โ | View Details |